摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,4,6-trimethylphenol formate | 61417-92-3

中文名称
——
中文别名
——
英文名称
2,4,6-trimethylphenol formate
英文别名
2,4,6-Trimethylphenyl formate;(2,4,6-trimethylphenyl) formate
2,4,6-trimethylphenol formate化学式
CAS
61417-92-3
化学式
C10H12O2
mdl
——
分子量
164.204
InChiKey
BSZIGDVUHBYMKC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    54 °C(Press: 0.5 Torr)
  • 密度:
    1.028±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.8
  • 重原子数:
    12
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    26.3
  • 氢给体数:
    0
  • 氢受体数:
    2

SDS

SDS:2cf5f9bd3560385a8bc71e722809b284
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2,4,6-trimethylphenol formate氢氧化钾 作用下, 以 甲醇 为溶剂, 反应 1.0h, 生成 2,4,6-三甲酚
    参考文献:
    名称:
    The Baeyer-Villiger Oxidation of Aromatic Aldehydes and Ketones with Hydrogen Peroxide Catalyzed by Selenium Compounds. A Convenient Method for the Preparation of Phenols
    摘要:
    一系列有机硒化合物被研究作为过氧化氢在拜耳-维利格氧化反应中的活化剂。结果发现,这是一种方便且经济的转化具有聚合环系或供电子取代基的芳香醛、乙酰苯的多甲氧基衍生物为酚类的方法。该方法使用由芳硒酸活化的过氧化氢作为氧化剂。
    DOI:
    10.1055/s-1989-27183
  • 作为产物:
    描述:
    参考文献:
    名称:
    The Baeyer-Villiger Oxidation of Aromatic Aldehydes and Ketones with Hydrogen Peroxide Catalyzed by Selenium Compounds. A Convenient Method for the Preparation of Phenols
    摘要:
    一系列有机硒化合物被研究作为过氧化氢在拜耳-维利格氧化反应中的活化剂。结果发现,这是一种方便且经济的转化具有聚合环系或供电子取代基的芳香醛、乙酰苯的多甲氧基衍生物为酚类的方法。该方法使用由芳硒酸活化的过氧化氢作为氧化剂。
    DOI:
    10.1055/s-1989-27183
点击查看最新优质反应信息

文献信息

  • [EN] CEPHEM COMPOUNDS<br/>[FR] CEPHEMES
    申请人:FUJISAWA PHARMACEUTICAL CO
    公开号:WO2005027909A1
    公开(公告)日:2005-03-31
    The present invention relates to a compound of the formula [I]: wherein R1 is lower alkyl or hydroxy (lower) alkyl, and R2 is hydrogen or amino protecting group, or R1 and R2 are bonded together and form lower alkylene ; R3 is -A-R6 wherein A is bond, -NHCO-(CH2CO)n-, lower alkylene, -NH-CO-CO- or the like, and R6 is (a) ou (b) wherein R7, R8, R9 and R10 are independently amino, guanidino, amidino or the like ; R4 is carboxy or protected carboxy; and R5 is amino or protected amino, or a pharmaceutically acceptable salt thereof, a process for preparing a compound of the formula [I], and a pharmaceutical composition comprising a compound of the formula [I] in admixture with a pharmaceutically acceptable carrier.
    本发明涉及一种公式的化合物[I]:其中R1是低级烷基或羟基(低级)烷基,R2是氢或基保护基团,或者R1和R2连接并形成低级亚烷基;R3是-A-R6,其中A是键,-NHCO-(CH2CO)n-,低级亚烷基,-NH-CO-CO-或类似物质,R6是(a)或(b)其中R7,R8,R9和R10是独立的基,基,脒基或类似物质;R4是羧基或受保护的羧基;R5是基或受保护的基,或药用可接受的盐,一种制备公式化合物[I]的方法,以及一种包括与药用可接受载体混合的公式化合物[I]的药物组合物。
  • COMPOUND, INK, INK CARTRIDGE AND INK JET RECORDING METHOD
    申请人:CANON KABUSHIKI KAISHA
    公开号:US20170247557A1
    公开(公告)日:2017-08-31
    A compound is represented by the following formula (1). In the compound represented by Formula (1), at least one of R 1 to R 24 is a group particularly high electron withdrawing property, such as a sulfonic acid group and a carboxylic acid group or a group having the next highest electron withdrawing property to the sulfonic acid group and the carboxylic acid group, such as a halogen atom.
    化合物由以下公式(1)表示。 在由公式(1)表示的化合物中,至少有一个R1到R24是具有特别高电子抽取性质的基团,例如磺酸基团和羧酸基团,或者具有次高电子抽取性质的基团,例如卤素原子。
  • [EN] CEPHEM COMPOUNDS<br/>[FR] COMPOSES CEPHEME
    申请人:FUJISAWA PHARMACEUTICAL CO
    公开号:WO2004039814A1
    公开(公告)日:2004-05-13
    The present invention relates to a compound of the formula [I]: wherein R1 is lower alkyl, hydroxy(lower)alkyl or halo(lower)alkyl, and R2 is hydrogen or amino protecting group, or R1 and R2 are bonded together and form lower alkylene or lower alkenylene; R3 is hydrogen or lower alkyl; R4 is ; R5 is carboxy or protected carboxy; and R6 is amino or protected amino, or a pharmaceutically acceptable salt thereof, a process for preparing a compound of the formula [I], and a pharmaceutical composition comprising a compound of the formula [I] in admixture with a pharmaceutically acceptable carrier.
    本发明涉及一种具有以下式[I]的化合物:其中R1是较低的烷基、羟基(较低)烷基或卤代(较低)烷基,R2是氢或基保护基,或者R1和R2结合在一起形成较低的烷基或较低的烯基;R3是氢或较低的烷基;R4是;R5是羧基或保护羧基;R6是基或保护基,或其药学上可接受的盐,一种制备上述式[I]化合物的方法,以及包含上述式[I]化合物与药学上可接受的载体混合物的药物组合物。
  • TITANIUM COMPOUNDS AND PROCESS FOR CYANATION OF IMINES
    申请人:Seayad Abdul Majeed
    公开号:US20110319629A1
    公开(公告)日:2011-12-29
    The present invention relates to titanium catalysts for synthesis reactions produced by bringing a reaction mixture comprising a titanium alkoxide and a ligand in contact with water, wherein the ligand is represented by the general formula (e): wherein R 1 , R 2 , R 3 , and R 4 are independently a hydrogen atom, an alkyl group, or the like, and (A) represents a group with two or more carbon atoms. The titanium catalysts may be isolated in solid form and may be stored. The invention further relates to a process for cyanation of imines, wherein the process comprises reacting an imine with a cyanating agent in the presence of the titanium catalyst.
    本发明涉及一种通过使包含醇盐和配体的反应混合物与接触而制得的用于合成反应的催化剂,其中配体由通式(e)表示:其中R1、R2、R3和R4各自独立地为氢原子、烷基组或其他类似物,且(A)表示具有两个或更多个碳原子的基团。所述催化剂可以以固体形式分离并储存。本发明还涉及一种亚胺化方法,该方法包括在催化剂存在下使亚胺化剂反应。
  • NON-AQUEOUS ELECTROLYTE AND ELECTRICITY STORAGE DEVICE
    申请人:UBE INDUSTRIES, LTD.
    公开号:US20150372349A1
    公开(公告)日:2015-12-24
    The present invention provides a nonaqueous electrolytic solution capable of improving electrochemical characteristics in the case of using an energy storage device at a high temperature and further capable of inhibiting the gas generation as well as a capacity retention rate after a high-temperature cycle, and also to provide an energy storage device using the same. Disclosed are a nonaqueous electrolytic solution having an electrolyte salt dissolved in a nonaqueous solvent, the nonaqueous electrolytic solution containing a phenyl ester compound represented by the following general formula (I), and an energy storage device. (In the formula, R f represents a fluoroalkyl group having 1 to 6 carbon atoms; X represents a halogen atom; each of p and q is an integer of 1 to 4; and (p+q) is 5 or less. A has a structure represented by —S(═O) 2 —, —C(═O)—, —C(═O)—O—, —C(═O)-L 1 -C(═O)—, —C(═O)-L 2 -P(═O)(OR)—O—, or —P(═O)(OR)—O—. Y represents a fluorine atom, a hydrogen atom, an alkyl group, an alkenyl group, an alkynyl group, or an aryl group; L 1 represents an alkylene group, an alkenylene group, an alkynylene group, or a direct bond; L 2 represents an alkylene group; and R represents an alkyl group. However, only when A is —S(═O) 2 —, Y may be a fluorine atom; and only when A is —C(═O)—, Y may be a hydrogen atom. At least one hydrogen atom in each group of the aforementioned alkyl group, alkenyl group, alkynyl group, aryl group, alkylene group, alkenylene group, and alkynylene group may be substituted with a halogen atom.)
    本发明提供了一种非电解质溶液,能够在高温下使用能量存储装置时改善电化学特性,并且在高温循环后能够抑制气体生成以及保持容量保留率,还提供了使用该非电解质溶液的能量存储装置。所述非电解质溶液包含溶解在非溶剂中的电解质盐,该非电解质溶液包含下述通式(I)所代表的苯酯化合物,以及能量存储装置。(在该式中,Rf代表具有1至6个碳原子的氟烷基;X代表卤素原子;p和q中的每一个是1至4的整数;以及(p+q)不超过5。A具有由—S(═O)2—、—C(═O)—、—C(═O)—O—、—C(═O)-L1-C(═O)—、—C(═O)-L2-P(═O)(OR)—O—或—P(═O)(OR)—O—表示的结构。Y代表原子、氢原子、烷基、烯基、炔基或芳基;L1代表烷基、烯基、炔基或直链键;L2代表烷基;R代表烷基。但是,仅当A为—S(═O)2—时,Y可以是原子;仅当A为—C(═O)—时,Y可以是氢原子。上述烷基、烯基、炔基、芳基、烷基、烯基和炔基中的每一组中至少一个氢原子可以被卤素原子取代。)
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫